This profound improvement in HF-related symptoms and physical limitations may be partially mediated by the effects of GLP-1 RAs on key obesity-related comorbidities, such as obstructive sleep apnoea (OSA), which is highly prevalent in HFpEF. Here, GLP1R is linked to obesity disorder.